USD 3.74
(-7.65%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 221.82 Million USD | 12.51% |
2022 | 197.16 Million USD | 18.27% |
2021 | 166.71 Million USD | -49.05% |
2020 | 327.23 Million USD | 81.05% |
2019 | 180.74 Million USD | 18.6% |
2018 | 152.39 Million USD | 5.09% |
2017 | 145.01 Million USD | 4.98% |
2016 | 138.14 Million USD | 599.8% |
2015 | 19.74 Million USD | 1.17% |
2014 | 19.51 Million USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 223.75 Million USD | 0.87% |
2024 Q2 | 242.65 Million USD | 8.45% |
2023 Q1 | 196.12 Million USD | -0.53% |
2023 FY | 221.82 Million USD | 12.51% |
2023 Q3 | 193.9 Million USD | -0.58% |
2023 Q2 | 195.04 Million USD | -0.55% |
2023 Q4 | 221.82 Million USD | 14.4% |
2022 Q1 | 200.13 Million USD | 20.05% |
2022 Q2 | 199.18 Million USD | -0.48% |
2022 Q3 | 198.18 Million USD | -0.5% |
2022 Q4 | 197.16 Million USD | -0.51% |
2022 FY | 197.16 Million USD | 18.27% |
2021 Q2 | 163.84 Million USD | -50.46% |
2021 Q3 | 165.08 Million USD | 0.75% |
2021 Q4 | 166.71 Million USD | 0.99% |
2021 Q1 | 330.73 Million USD | 1.07% |
2021 FY | 166.71 Million USD | -49.05% |
2020 FY | 327.23 Million USD | 81.05% |
2020 Q3 | 323.78 Million USD | 1.04% |
2020 Q1 | 181.92 Million USD | 0.65% |
2020 Q4 | 327.23 Million USD | 1.07% |
2020 Q2 | 320.44 Million USD | 76.14% |
2019 FY | 180.74 Million USD | 18.6% |
2019 Q2 | 178.46 Million USD | 0.64% |
2019 Q3 | 179.6 Million USD | 0.64% |
2019 Q1 | 177.33 Million USD | 16.36% |
2019 Q4 | 180.74 Million USD | 0.64% |
2018 Q1 | 146.82 Million USD | 1.24% |
2018 Q3 | 150.5 Million USD | 1.25% |
2018 Q4 | 152.39 Million USD | 1.25% |
2018 FY | 152.39 Million USD | 5.09% |
2018 Q2 | 148.64 Million USD | 1.24% |
2017 Q2 | 141.52 Million USD | 1.22% |
2017 FY | 145.01 Million USD | 4.98% |
2017 Q4 | 145.01 Million USD | 1.23% |
2017 Q3 | 143.26 Million USD | 1.23% |
2017 Q1 | 139.82 Million USD | 1.22% |
2016 Q4 | 138.14 Million USD | 1.2% |
2016 Q1 | 19.8 Million USD | 0.31% |
2016 FY | 138.14 Million USD | 599.8% |
2016 Q2 | 134.78 Million USD | 580.7% |
2016 Q3 | 136.49 Million USD | 1.27% |
2015 Q1 | 19.56 Million USD | 0.3% |
2015 FY | 19.74 Million USD | 1.17% |
2015 Q2 | 19.62 Million USD | 0.3% |
2015 Q4 | 19.74 Million USD | 0.26% |
2015 Q3 | 19.68 Million USD | 0.31% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | 19.51 Million USD | 0.0% |
2014 FY | 19.51 Million USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott Laboratories | 15.87 Billion USD | 98.602% |
Allurion Technologies Inc. | 41.85 Million USD | -429.964% |
Artivion, Inc. | 359.34 Million USD | 38.268% |
Avanos Medical, Inc. | 209.1 Million USD | -6.087% |
Butterfly Network, Inc. | 25.02 Million USD | -786.351% |
Butterfly Network, Inc. | 25.02 Million USD | -786.351% |
Bio-Rad Laboratories, Inc. | 1.4 Billion USD | 84.222% |
Boston Scientific Corporation | 9.49 Billion USD | 97.663% |
Perspective Therapeutics, Inc. | - USD | -Infinity% |
CONMED Corporation | 991.25 Million USD | 77.622% |
Edwards Lifesciences Corporation | 694.9 Million USD | 68.078% |
Paragon 28, Inc. | 112.03 Million USD | -98.007% |
Glaukos Corporation | 383.73 Million USD | 42.193% |
Globus Medical, Inc. | 520.4 Million USD | 57.374% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -792.808% |
Integer Holdings Corporation | 1.04 Billion USD | 78.69% |
Medtronic plc | 26.04 Billion USD | 99.148% |
Owlet, Inc. | 15.21 Million USD | -1357.854% |
Penumbra, Inc. | 234.34 Million USD | 5.341% |
Vicarious Surgical Inc. | 14.83 Million USD | -1395.597% |
Smith & Nephew plc | 3.08 Billion USD | 92.807% |
Sonendo, Inc. | 40.35 Million USD | -449.744% |
STERIS plc | 3.38 Billion USD | 93.443% |
Stryker Corporation | 12.99 Billion USD | 98.293% |
Vapotherm, Inc. | 112.39 Million USD | -97.369% |
Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | 96.3% |